Botanix PharmaceuticalsBXPHF Days Payable is 351.87 as of Dec. 2025, which is 43% below its 10-year median of 615.61. The stock has 7 warning signs investors should review. Among 702 Biotechnology companies, Botanix Pharmaceuticals ranks better than 76.5% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BXPHF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Botanix Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Botanix Pharmaceuticals Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Botanix Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Botanix Pharmaceuticals's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Botanix Pharmaceuticals (BXPHF) has a Days Payable of 351.87 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Botanix Pharmaceuticals and its competitors. This is 43% below median its historical median of 615.61. Over the past decade, Botanix Pharmaceuticals' Days Payable has ranged from 414.78 to 615.61. According to the industry distribution chart, Botanix Pharmaceuticals ranks #165 out of 702 companies in the Biotechnology industry, placing it in the top 23.5%.
Is Botanix Pharmaceuticals' Days Payable too high?
Botanix Pharmaceuticals' current Days Payable of 351.87 is 43% below median its 10-year median of 615.61. Over the past 10 years, this metric has ranged from a low of 414.78 to a high of 615.61. The Biotechnology industry median Days Payable is 113.10. Botanix Pharmaceuticals' value of 351.87 is 211.1% above this industry median. Based on the distribution chart, Botanix Pharmaceuticals ranks #165 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Botanix Pharmaceuticals' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Botanix Pharmaceuticals ranks #165 out of 702 companies for Days Payable. This places Botanix Pharmaceuticals in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.10. Botanix Pharmaceuticals' value of 351.87 is 211.1% above this benchmark. Historically, Botanix Pharmaceuticals' own Days Payable has ranged from 414.78 to 615.61 over the past decade. While the company's 10-year median is 615.61 vs. the industry median of 113.10, Botanix Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Botanix Pharmaceuticals's current Days Payable of 351.87 is 211.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Botanix Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Botanix Pharmaceuticals's current Days Payable is 351.87, which is 43% below median its own 10-year median of 615.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (BXPHF) has a current Days Payable of 351.87. The current Days Payable is 351.87, which is 43% below median its 10-year median of 615.61 and 211.1% above the Biotechnology industry median of 113.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Botanix Pharmaceuticals (BXPHF), the current Days Payable is 351.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXPHF has been successfully added to your 